ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering
August 03, 2021PharmaCyte Biotech, Inc. (OTCQB: PMCBD) (PharmaCyte or Company) today announced that The Nasdaq Stock Market LLC (Nasdaq) has approved the listing of the Company's common stock on Nasdaq. -
PharmaCyte Conducts Final Audit of Mfg. Facility
May 19, 2020PharmaCyte Biotech, a biotechnology company focused on developing cellular therapies for cancer and diabetes, has announced that cGMP Validation, the company’s GMP consultant, is conducting its final audit of the manufacturing facility in Thailand.
Pharma Sources Insight January 2025
